This report from Life Science Intelligence provides the latest market data for the Global Oncology Embolization Agents Market. Information covered by this report includes:
This report covers the impact of COVID-19 on the embolization agents market, including a recent forecast from 2020 to 2025. COVID-19 has also impacted leading competitors, such as Boston Scientific, Merit Medical, Medtronic, Sirtex, and others. The report provides insights into trends, drivers, and limiters of the oncology embolization agents market, as well as highlights potential opportunities.
Boston Scientific BTG
Cordis Cardinal Health
Merit Medical Biosphere